
1211443-61-6
Product name: 2-chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamideCAS:1211443-61-6. MF:C14H17ClN4O. MW:292.76. EINECS:808-234-2. MDL No.:MFCD20527881
Add to Inquiry
CAS 103694-84-4 | CARDIO-SPECT
Name: CARDIO-SPECTCAS number: 103694-84-4Molecular formula: C24H44BCuF4N4O4Molecular weight: 602.98EINECS number:MDL No.:MFCD02092733
Add to Inquiry
67911-21-1 Caronic Anhydride
CAS:67911-21-1MF:C7H8O3MW:140.14EINECS:MDL No.:MFCD09751198
Add to Inquiry
151213-40-0 N-NONANE
CAS:151213-40-0MF:C7H14N2MW:126.2EINECS:604-778-8MDL No.:MFCD04116298
Add to Inquiry
17348-59-3 2-isopropoxy-2-methylpropane
Product name: 2-isopropoxy-2-methylpropaneCAS number: 17348-59-3Molecular formula: C7H16OMolecular weight: 116.2EINECS number: 241-373-1MDL No.:
Add to Inquiry
1869118-24-0
Product name: Carbamic acid, N - [5- [(4-methylphenyl) sulfonyl] -5H-pyrolo [2,3-b] pyrazin-2-yl] -, ethyl esterCAS number: 1869118-24-0Molecular formula: C16H16N4O4SMolecular weight: 360.39EINECS
Add to Inquiry
1491158-62-3 Fmoc-Lys(Pal-Glu-OtBu)-OH
Product name: Fmoc-Lys(Pal-Glu-OtBu)-OHCAS number: 1491158-62-3Molecular formula: C46H69N3O8Molecular weight: 792.06EINECS number:MDL No.:MFCD27952849
Add to Inquiry
438056-69-0 4-(4-aminophenyl)morpholin-3-one
Product name:CAS:438056-69-0. MF:C10H12N2O2. MW:192.21. EINECS:610-147-8. MDL No.:MFCD08236742
Add to Inquiry
312753-53-0
Product Name:5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochlorideCAS:312753-53-0. MF:C13H20ClN. MW:225.76. EINECS:691-331-5. MDL No.:MFCD13185940
Add to Inquiry
122111-01-7
Product name:CAS:122111-01-7. MF:C19H14F2O6. MW:376.31. EINECS:601-822-8. MDL No.:MFCD00209570
Add to Inquiry
17025-47-7 Phenyl Tribromomethyl Sulfone
CAS:17025-47-7. MF:C7H5Br3O2S. MW:392.89. EINECS:241-096-6. MDL No.:MFCD00060068
Add to Inquiry
62459-02-3
CAS:62459-02-3. MF:C14H15N3O2. MW:257.29. EINECS:1533716-785-6. MDL No.:MFCD09839775
Add to Inquiry
China Palbociclib intermediate Manufacturers Factory Suppliers
Our company has a professional R&D team, so the advanced technology intermediate, intermediate stock, 2 Cyanophenylboronic acid design is novel and beautiful, with extremely high economic benefits. Our high standards and strict requirements are necessary factors to achieve product quality. High-quality products and considerate service are only to serve every customer well.The Palbociclib intermediate produced by the company has been sold to various provinces, cities, prefectures, counties and districts across the country, and exported to many countries and regions in the world. Our aim is: design and create wealth, innovate and realize value, promote products with science and technology, and make good brand with good faith. We have a deep understanding of the unique needs and challenges of different industries and markets. We believe in building long-term relationships with our clients through our exceptional service and personalized solutions. We insist on safe operation as the fundamental, continuously implement safety inspection and supervision, and continuously improve the safety management level. We change the concept of innovation, we innovate mechanism and situation and uphold the concept of integrity management, we seek survival by quality, development by quality and we want efficiency from quality. Our company promises: reasonable prices, short production time and satisfactory after-sales service, we also welcome you to visit our factory at any time you want. All of our employees are striving to build our company into a world-class enterprise as soon as possible.WEBAug 25, 2022 · Palbociclib mainly binds to CDK4 protein through a strong hydrogen bond and several weak π-cation and π-alkyl bonds (Supplementary Figure S8). The introduction of 10-HCPT structure...
WEBOne of these efforts has resulted in the development of Palbociclib, a first in class inhibitor of cyclin dependent kinases 4 and 6 (CDK4 and CDK6), which was granted accelerated approval from the...
WEBMay 13, 2019 · This protocol involved methylation, nucleophilic substitution, bromination, nucleophilic substitution, Heck reaction, ring closure,...
WEBOct 16, 2021 · Palbociclib is an oral CDK4/6 inhibitor indicated in HR+/HER2- advanced or metastatic breast cancer in combination with hormonotherapy. Its main toxicity is neutropenia. The aim of...
WEBJun 21, 2019 · Bromopyrimidine 293 was treated with crotonic acid 285 mediated by 3 mol% of PdCl 2 (PhCN) 2 catalyst, 7.5 mol% of P(o-tol) 3 ligand, and DIPEA in DMF at 130°C, producing the...
WEBOne of these efforts has resulted in the development of Palbociclib, a first in class inhibitor of cyclin dependent kinases 4 and 6 (CDK4 and CDK6), which was granted accelerated...
